Immundiagnostik
Private Company
Total funding raised: $3.7M
Overview
Immundiagnostik AG is a long-established, privately-held German diagnostics company focused on niche immunological assays and reagents. It operates a diversified business model encompassing in-house development and manufacturing of ELISA/EIA kits, LC-MS/MS applications, antibodies, and contract analytical services. The company targets specific diagnostic needs in areas like celiac disease and histamine intolerance, leveraging its expertise to serve clinical labs and research institutions. Its strategy is built on certified quality, continuous innovation, and direct customer relationships.
Technology Platform
Integrated immunodiagnostics platform specializing in ELISA/EIA, LC-MS/MS/HPLC applications, PCR, photometric tests, and proprietary antibody (polyclonal/monoclonal) development.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Immundiagnostik competes in specialized segments against other focused diagnostic companies (e.g., Euroimmun, Thermo Fisher's specialty diagnostics units) and the research reagent divisions of larger biotech firms. Its competitive advantage lies in its deep niche expertise, integrated antibody and assay development, and reputation for quality in its specific diagnostic areas.